Delivery Order SPE2DB22D2211-SPE2DB25FSCAF
Award Date 8/1/25
Potential Completion Date 8/22/25
Potential Value $44K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded a delivery order valued at $5,772.72 to AmerisourceBergen Drug Corp for the supply of Novoseven RT 2 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement extending through December 2026. The delivery order is scheduled for completion by August 15, 2025, with fulfillment...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $27,604.30 order is for the supply of NOVOSEVEN RT 2 MG VIALS, a specialized pharmaceutical product. The delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOSEVEN RT 5 MG VIALS, a medication, with a ceiling value of $7,277.44 and a period of performance through June 18, 2025. The award is not set aside and is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp is the prime contractor and will be...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $82,935.48 firm-fixed-price contract is for the supply of NovoSeven RT 5 mg vials, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- The Defense Logistics Agency awarded a $5,418.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561309677 NovoSeven RT 2 mg vials. The contract has a period of performance from June 21, 2023 through July 13, 2023 and will be performed in Conshohocken, Pennsylvania. NovoSeven is a recombinant factor VIIa product used to treat bleeding episodes in patients with hemophilia A or B with inhibitors. The Defense Logistics Agency manages the Department of Defense's global...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOSEVEN RT 5 MG VIALS, a specialized pharmaceutical product. The contract has a firm fixed price of $7,277.44 and a completion date of June 17, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This federal contract award is for the delivery of NovoSeven RT 5 mg vials to the Defense Logistics Agency (DLA). The $80,051.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2025, with a completion date of April 4, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOSEVEN RT 2 MG VIALS. The contract has a potential value of $21,675.92 and a performance completion date of January 12, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,760.43 and is a delivery order contract for the supply of 4563408586 NOVOSEVEN RT 2 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2024. The contract was awarded on January 23, 2024 and does not have a set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of NovoSeven RT 5 mg vials, a medication used to treat hemophilia. The contract has a ceiling value of $34,556.45 and runs through July 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...